Go Pro

Crescent Capital BDC, Inc. (NASDAQ:CCAP) Receives Consensus Rating of "Hold" from Analysts

Crescent Capital BDC logo with Finance background
Image from MarketBeat Media, LLC.

Key Points

  • Analysts maintain a “Hold” consensus on Crescent Capital BDC, with four hold ratings and two buys; the average 12-month price target is $13.30, though several firms recently lowered their targets.
  • Shares opened at $11.08 and have declined 3.1%, while the company’s latest quarterly earnings of $0.36 per share slightly missed the $0.37 consensus estimate.
  • Crescent declared a quarterly dividend of $0.34 per share, equal to $1.36 annualized and a 12.3% indicated yield, offering significant income appeal despite the company’s weak reported net margin and high payout ratio.
  • Five stocks to consider instead of Crescent Capital BDC.

Crescent Capital BDC, Inc. (NASDAQ:CCAP - Get Free Report) has earned a consensus rating of "Hold" from the six brokerages that are currently covering the firm, Marketbeat reports. Four analysts have rated the stock with a hold rating and two have assigned a buy rating to the company. The average 1 year price target among brokers that have updated their coverage on the stock in the last year is $13.30.

A number of analysts recently commented on the stock. B. Riley Financial lowered their target price on shares of Crescent Capital BDC from $13.50 to $12.50 and set a "neutral" rating for the company in a research note on Wednesday. LADENBURG THALM/SH SH decreased their price target on shares of Crescent Capital BDC from $15.00 to $14.00 and set a "buy" rating for the company in a report on Wednesday. Wells Fargo & Company lowered their price objective on shares of Crescent Capital BDC from $12.00 to $11.00 and set an "equal weight" rating for the company in a research note on Wednesday. Oppenheimer downgraded Crescent Capital BDC from an "outperform" rating to a "market perform" rating and cut their target price for the company from $19.00 to $16.00 in a research report on Friday, May 15th. Finally, Wall Street Zen lowered Crescent Capital BDC from a "hold" rating to a "sell" rating in a research note on Saturday, July 25th.

Read Our Latest Report on Crescent Capital BDC

Crescent Capital BDC Trading Down 3.1%

Shares of NASDAQ:CCAP opened at $11.08 on Thursday. The business's 50-day moving average is $11.16 and its 200 day moving average is $12.36. The company has a debt-to-equity ratio of 1.35, a current ratio of 1.53 and a quick ratio of 1.53. Crescent Capital BDC has a 1 year low of $10.64 and a 1 year high of $16.03. The firm has a market capitalization of $408.30 million, a P/E ratio of -123.11 and a beta of 0.52.

Crescent Capital BDC (NASDAQ:CCAP - Get Free Report) last issued its quarterly earnings results on Monday, August 10th. The company reported $0.36 earnings per share for the quarter, missing the consensus estimate of $0.37 by ($0.01). Crescent Capital BDC had a positive return on equity of 8.88% and a negative net margin of 2.02%.The business had revenue of $5.12 million during the quarter, compared to analyst estimates of $37.12 million. On average, research analysts predict that Crescent Capital BDC will post 1.38 earnings per share for the current fiscal year.

Crescent Capital BDC Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Thursday, October 15th. Stockholders of record on Wednesday, September 30th will be issued a $0.34 dividend. The ex-dividend date of this dividend is Wednesday, September 30th. This represents a $1.36 dividend on an annualized basis and a dividend yield of 12.3%. Crescent Capital BDC's dividend payout ratio is currently -1,511.11%.

Insider Activity

In other news, CEO Jason Breaux bought 5,000 shares of the firm's stock in a transaction that occurred on Wednesday, May 20th. The stock was purchased at an average price of $11.19 per share, with a total value of $55,950.00. Following the completion of the acquisition, the chief executive officer directly owned 52,636 shares of the company's stock, valued at $588,996.84. This trade represents a 10.50% increase in their position. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, President Henry Chung bought 4,500 shares of the firm's stock in a transaction that occurred on Thursday, May 21st. The shares were purchased at an average cost of $11.45 per share, with a total value of $51,525.00. Following the acquisition, the president directly owned 20,722 shares of the company's stock, valued at approximately $237,266.90. This trade represents a 27.74% increase in their ownership of the stock. The SEC filing for this purchase provides additional information. Company insiders own 1.23% of the company's stock.

Institutional Trading of Crescent Capital BDC

A number of hedge funds and other institutional investors have recently made changes to their positions in the business. Ieq Capital LLC lifted its position in Crescent Capital BDC by 3.0% during the fourth quarter. Ieq Capital LLC now owns 25,470 shares of the company's stock valued at $358,000 after purchasing an additional 746 shares during the period. Mariner LLC grew its position in Crescent Capital BDC by 0.3% during the 4th quarter. Mariner LLC now owns 451,774 shares of the company's stock worth $6,369,000 after purchasing an additional 1,492 shares during the period. Northwestern Mutual Wealth Management Co. purchased a new position in shares of Crescent Capital BDC during the 4th quarter valued at about $27,000. LMG Wealth Partners LLC raised its stake in shares of Crescent Capital BDC by 17.8% during the 1st quarter. LMG Wealth Partners LLC now owns 13,548 shares of the company's stock valued at $165,000 after buying an additional 2,048 shares during the last quarter. Finally, NewEdge Advisors LLC lifted its holdings in shares of Crescent Capital BDC by 20.2% in the 4th quarter. NewEdge Advisors LLC now owns 12,279 shares of the company's stock valued at $173,000 after buying an additional 2,066 shares during the period. Institutional investors and hedge funds own 49.46% of the company's stock.

Key Stories Impacting Crescent Capital BDC

Here are the key news stories impacting Crescent Capital BDC this week:

  • Positive Sentiment: Crescent maintained its quarterly base dividend at $0.34 per share and declared an additional $0.03 special dividend. The base dividend equates to an annualized yield of approximately 11.9% at the referenced share price, supporting the stock’s income appeal. Crescent Capital BDC Q2 2026 earnings and dividend announcement
  • Positive Sentiment: Management expects leverage to return to its target range during the second half of 2026 while continuing the $0.34 dividend. Improved balance-sheet positioning could support future earnings and distribution stability. Crescent Capital BDC leverage outlook
  • Neutral Sentiment: Ladenburg Thalmann lowered its price target from $15 to $14 but retained a Buy rating, implying substantial upside from the referenced price. The target reduction nevertheless signals more cautious valuation expectations. Benzinga analyst action
  • Negative Sentiment: Wells Fargo cut its target from $12 to $11 and maintained an Equal Weight rating, indicating limited near-term upside and adding pressure to the shares. The Fly analyst action
  • Negative Sentiment: Second-quarter earnings modestly missed consensus, with earnings per share of $0.36 versus the $0.37 estimate. The miss likely contributed to investor caution despite the dividend declarations and leverage guidance. Crescent Capital BDC second-quarter earnings results

About Crescent Capital BDC

(Get Free Report)

Crescent Capital BDC, Inc is a closed-end, externally managed business development company that provides flexible financing solutions to middle market companies in the United States. Trading on the Nasdaq under the ticker CCAP, the firm offers investors exposure to a diversified portfolio of debt and equity instruments, targeting businesses with attractive risk-adjusted return profiles. Its primary objective is to generate current income through interest payments and potential capital appreciation via selective equity co-investments.

The company’s investment strategy emphasizes senior secured loans, unsecured second-lien loans, mezzanine debt, as well as preferred and common equity co-investments.

Further Reading

Analyst Recommendations for Crescent Capital BDC (NASDAQ:CCAP)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Should You Invest $1,000 in Crescent Capital BDC Right Now?

Before you consider Crescent Capital BDC, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Crescent Capital BDC wasn't on the list.

While Crescent Capital BDC currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

(Almost)  Everything You Need To Know About The EV Market Cover

Looking to profit from the electric vehicle mega-trend? Click the link to see our list of which EV stocks show the most long-term potential.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines